Imperial Petroleum (IMPP) Q4 Earnings Surge 250% YoY to $0.35 EPS on Strong Tanker UtilizationMarch 7, 2026
Stifel starts Lexeo at buy, cites ataxia and Alzheimer’s drug candidates (LXEO) Markets December 1, 2023 ismagilov Stifel has began protection of newly public Lexeo Therapeutics (NASDAQ:LXEO) with a purchase ranking, saying it was bullish on…
Biogen’s new Alzheimer’s drug to raise Medicare costs (NASDAQ:BIIB) Markets May 14, 2023 zimmytws Leqembi, the brand new Alzheimer’s remedy developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY), might add $2B – $5B…
Lilly posts Phase 3 data to compare Alzheimer’s drug vs. Biogen’s (NYSE:LLY) Markets December 1, 2022 koto_feja Eli Lilly (NYSE:LLY) shared information from a Part 3 trial for its Alzheimer’s illness donanemab, evaluating its efficiency in…
How might the CMS decision on Biogen’s Aduhelm impact other Alzheimer’s candidates? Markets April 10, 2022 selvanegra/iStock through Getty Photos Regardless of the Facilities for Medicare & Medicaid Providers’ (CMS) determination on April 7 to severely…
